Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 107.50
Bid: 106.50
Ask: 107.00
Change: 1.50 (1.42%)
Spread: 0.50 (0.469%)
Open: 106.00
High: 108.50
Low: 106.00
Prev. Close: 106.00
MCB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Full year trading update

14 Jul 2021 07:00

RNS Number : 1274F
McBride PLC
14 July 2021
 
14 July 2021

 

McBride plc

 

Full year trading update

 

McBride plc (the "Group"), the leading European manufacturer and supplier of Private Label and Contract Manufactured products for the domestic household and professional cleaning and hygiene markets, today provides a trading update for the year ended 30 June 2021.

 

Adjusted operating profit and adjusted profit before tax for the year are anticipated to be in line with current market expectations.

 

We continue to experience the uneven levels of demand noted in our May trading update. The impact of Covid-19 lockdowns on consumer behaviour has seen a continuation of weaker laundry volumes and stronger demand for cleaners and dishwasher products in the second half, although demand for cleaners and dishwasher tablets softened in the final quarter. These weaker run rates, coupled with short-term consumer stockpiling in the comparative period in the early stage of lockdown in 2020, have resulted in lower second half revenues and full year revenues at constant currency 4.0% lower than the previous year. In the divisions, Powders was significantly impacted with sales declining 16%, reflecting the effect of low laundry volumes both to consumer and professional markets, with sales in the other divisions declining by much smaller amounts.

 

The raw material environment remains challenging, both in terms of supply availability and exceptional price increases. The Group continues to discuss margin recovery actions with our customers, mostly across liquids categories. Our approach has been to apply an immediate variable pricing surcharge to sales contracts, based upon certain key commodity prices, with discussions and finalisation ongoing at this time.

 

Net debt (including IFRS 16) closed at circa £119m (30 June 2020: £101.5m), in line with our internal expectations. As highlighted at the interim stage, the increase in net debt includes a circa £15m impact from a return to more regular levels of working capital following the exceptionally low inventory levels at 30 June 2020 following destocking as a result of Covid-19. Debt cover on an accounting basis is expected at approximately 2.6x and hence under our new capital allocation policy, as announced on 23 February 2021, the Board does not expect to propose a final dividend for the year ended 30 June 2021.

 

Banking covenants on debt cover are expected to be approximately 1.4x, well within our covenant limit of 3.0x. The Group continues to have material headroom against its revolving credit facility of €175m.

 

The Group will announce its preliminary results for the year ended 30 June 2021 on 7 September 2021.

 

 

For further information, please contact:

 

McBride plc

Chris Smith, Chief Executive Officer

0161 203 7570

Mark Strickland, Chief Finance Officer

0161 203 7570

FTI Consulting

020 3727 1017

Ed Bridges, Nick Hasell

 

 

Note: This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation which came into effect on 3 July 2016.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEXLFFFDLZBBX
Date   Source Headline
2nd May 20249:21 amRNSHolding(s) in Company
30th Apr 20247:00 amRNSTrading Update
8th Apr 202411:24 amRNSHolding(s) in Company
8th Apr 202411:22 amRNSHolding(s) in Company
5th Apr 20249:53 amRNSHolding(s) in Company
28th Mar 20243:20 pmRNSDirector/PDMR Shareholding
25th Mar 20241:52 pmRNSDirector/PDMR Shareholding
13th Mar 20247:00 amRNSCapital Markets Day
28th Feb 20242:30 pmRNSDirector/PDMR Shareholding
27th Feb 20247:00 amRNSHalf-year Report
16th Jan 20247:00 amRNSTrading Update
13th Dec 20231:47 pmRNSDirector/PDMR Shareholding
20th Nov 20235:55 pmRNSDirector/PDMR Shareholding
20th Nov 20235:39 pmRNSResult of AGM
20th Nov 20237:00 amRNSAGM Trading Update
25th Oct 202310:22 amRNSTermination of ‘upside sharing’ mechanism
19th Oct 20237:00 amRNSTrading Update
17th Oct 20235:42 pmRNSPosting of ARA and Notice of AGM
4th Oct 20235:24 pmRNSVesting of RSU Awards
29th Sep 20237:00 amRNSDirector/PDMR Shareholding
22nd Sep 20235:33 pmRNSDirector/PDMR Shareholding
21st Sep 202310:54 amRNSDirector/PDMR Shareholding
19th Sep 20237:00 amRNSFinal Results
14th Jul 20237:00 amRNSFull year trading update
13th Jun 20237:00 amRNSDirector/PDMR Shareholding
31st May 20235:31 pmRNSDirectorate Change
25th May 20239:38 amRNSDirector Declaration
2nd May 20237:00 amRNSDirector/PDMR Shareholding
25th Apr 20237:00 amRNSTrading Update
11th Apr 20232:08 pmRNSDirector/PDMR Shareholding
3rd Apr 20232:39 pmRNSDirector/PDMR Shareholding
31st Mar 202312:27 pmRNSDirector/PDMR Shareholding
21st Mar 20235:59 pmRNSDirector/PDMR Shareholding
28th Feb 20237:00 amRNSHalf-year Report
1st Feb 20234:40 pmRNSSecond Price Monitoring Extn
1st Feb 20234:35 pmRNSPrice Monitoring Extension
1st Feb 20238:46 amRNSDirector Declaration
17th Jan 20237:00 amRNSTrading Update
11th Jan 20239:01 amRNSDirector Declaration
22nd Dec 20224:23 pmRNSDirector/PDMR Shareholding
13th Dec 20222:51 pmRNSDirector/PDMR Shareholding
16th Nov 20224:42 pmRNSAGM Statement
16th Nov 20227:00 amRNSAGM Trading Update
17th Oct 20227:00 amRNSAnnual Report 2022 and Annual General Meeting 2022
5th Oct 20225:55 pmRNSDirector/PDMR Shareholding
3rd Oct 20225:07 pmRNSRedemption of B Shares
29th Sep 202212:49 pmRNSFinal Results
29th Sep 202211:51 amRNSAmended Financing Agreement
29th Sep 20227:00 amRNSPreliminary results timing
6th Sep 20222:51 pmRNSBoard Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.